BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 8276736)

  • 1. Improvement in fluoxetine-associated sexual dysfunction in patients switched to bupropion.
    Walker PW; Cole JO; Gardner EA; Hughes AR; Johnston JA; Batey SR; Lineberry CG
    J Clin Psychiatry; 1993 Dec; 54(12):459-65. PubMed ID: 8276736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluoxetine-induced sexual dysfunction and an open trial of yohimbine.
    Jacobsen FM
    J Clin Psychiatry; 1992 Apr; 53(4):119-22. PubMed ID: 1564046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluoxetine-induced sexual dysfunction.
    Herman JB; Brotman AW; Pollack MH; Falk WE; Biederman J; Rosenbaum JF
    J Clin Psychiatry; 1990 Jan; 51(1):25-7. PubMed ID: 2295587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Switching to moclobemide to reverse fluoxetine-induced sexual dysfunction in patients with depression.
    Ramasubbu R
    J Psychiatry Neurosci; 1999 Jan; 24(1):45-50. PubMed ID: 9987207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of serotonin in sexual dysfunction: fluoxetine-associated orgasm dysfunction.
    Zajecka J; Fawcett J; Schaff M; Jeffriess H; Guy C
    J Clin Psychiatry; 1991 Feb; 52(2):66-8. PubMed ID: 1993638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of sexual dysfunction associated with antidepressant agents: a prospective multicenter study of 1022 outpatients. Spanish Working Group for the Study of Psychotropic-Related Sexual Dysfunction.
    Montejo AL; Llorca G; Izquierdo JA; Rico-Villademoros F
    J Clin Psychiatry; 2001; 62 Suppl 3():10-21. PubMed ID: 11229449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double-blind comparison between bupropion XL and venlafaxine XR: sexual functioning, antidepressant efficacy, and tolerability.
    Thase ME; Clayton AH; Haight BR; Thompson AH; Modell JG; Johnston JA
    J Clin Psychopharmacol; 2006 Oct; 26(5):482-8. PubMed ID: 16974189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of antidepressant activity of fluoxetine by cyproheptadine in three patients.
    Feder R
    J Clin Psychiatry; 1991 Apr; 52(4):163-4. PubMed ID: 2016249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal of fluoxetine-induced anorgasmia by cyproheptadine in two patients.
    McCormick S; Olin J; Brotman AW
    J Clin Psychiatry; 1990 Sep; 51(9):383-4. PubMed ID: 2211550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term fluoxetine treatment of late luteal phase dysphoric disorder.
    Pearlstein TB; Stone AB
    J Clin Psychiatry; 1994 Aug; 55(8):332-5. PubMed ID: 8071300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sexual dysfunction during antidepressant treatment.
    Balon R; Yeragani VK; Pohl R; Ramesh C
    J Clin Psychiatry; 1993 Jun; 54(6):209-12. PubMed ID: 8331089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of fluoxetine-induced sexual dysfunction with bupropion: a case report.
    Labbate LA; Pollack MH
    Ann Clin Psychiatry; 1994 Mar; 6(1):13-5. PubMed ID: 7951639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Care of the sexually active depressed patient.
    Hirschfeld RM
    J Clin Psychiatry; 1999; 60 Suppl 17():32-5; discussion 46-8. PubMed ID: 10446740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacologic modification of psychosexual dysfunction.
    Crenshaw TL; Goldberg JP; Stern WC
    J Sex Marital Ther; 1987; 13(4):239-52. PubMed ID: 3121861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluoxetine-induced yawning and anorgasmia reversed by cyproheptadine treatment.
    Cohen AJ
    J Clin Psychiatry; 1992 May; 53(5):174. PubMed ID: 1592848
    [No Abstract]   [Full Text] [Related]  

  • 16. Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder.
    Fava M; McCall WV; Krystal A; Wessel T; Rubens R; Caron J; Amato D; Roth T
    Biol Psychiatry; 2006 Jun; 59(11):1052-60. PubMed ID: 16581036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resolution of sexual dysfunction during double-blind treatment of major depression with reboxetine or paroxetine.
    Baldwin D; Bridgman K; Buis C
    J Psychopharmacol; 2006 Jan; 20(1):91-6. PubMed ID: 16204325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Individual and dyadic barriers to a pharmacotherapeutic treatment of hypoactive sexual desire disorders: results and implications from a small-scale study with bupropion.
    Hartmann UH; Rüffer-Hesse C; Krüger TH; Philippsohn S
    J Sex Marital Ther; 2012; 38(4):325-48. PubMed ID: 22712818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, double-blind, placebo-controlled study of the efficacy and safety of bupropion for treating hypoactive sexual desire disorder in ovulating women.
    Safarinejad MR; Hosseini SY; Asgari MA; Dadkhah F; Taghva A
    BJU Int; 2010 Sep; 106(6):832-9. PubMed ID: 20151970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A placebo-controlled comparison of the effects on sexual functioning of bupropion sustained release and fluoxetine.
    Coleman CC; King BR; Bolden-Watson C; Book MJ; Segraves RT; Richard N; Ascher J; Batey S; Jamerson B; Metz A
    Clin Ther; 2001 Jul; 23(7):1040-58. PubMed ID: 11519769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.